miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients
Non-small-cell lung cancer (NSCLC) is the most common malignancy worldwide. Platinum-based chemotherapy is the standard of care for these patients. Recent research showed that miR-7 methylation status is a bio...